Shimadzu Corporation acquired a 75% stake in Plasmion GmbH, making it a subsidiary on April 29, 2026, integrating its SICRIT® ion source technology into Shimadzu’s mass spectrometry platform.
Plasmion, based in Augsburg, Germany, specializes in developing and manufacturing ion sources for mass spectrometers. The company's proprietary SICRIT® technology enables high-sensitivity real-time analysis without complex sample pretreatment, with applications in healthcare, environmental monitoring, and food & beverage analysis. Shimadzu Corporation, a leading manufacturer of analytical instruments, aims to leverage Plasmion’s innovation to advance its next-generation mass spectrometers.
Deal structure and financing
The deal specifics regarding equity and debt remain undisclosed. However, the transaction involves Plasmion's founders retaining a 25% stake in the company while remaining actively involved in management. Shimadzu did not disclose any details about lock-up terms or IPO optionality for Plasmion. No information is available on the lead banks involved in the financing.
Strategic context
Shimadzu’s acquisition of Plasmion underscores its strategic move to enhance technological leadership in mass spectrometry through SICRIT® technology. This deal marks HTGF's first exit of a portfolio company to a Japanese corporation, highlighting Germany's deep tech capabilities and Shimadzu’s global expansion strategy.
Plasmion's founders, supported by HTGF since January 2019, are committed to advancing their innovative ion source technology in partnership with Shimadzu. The acquisition is expected to accelerate Plasmion’s growth trajectory and broaden its market reach through Shimadzu's established distribution networks across various sectors including analytics, quality control, pharma, and food & beverage.
Regulatory path
The transaction did not require any regulatory approvals as it falls below the notification thresholds in Germany and Japan for merger control reviews. Given the deal size and the parties involved, no HSR filings were required under U.S. antitrust laws or EU competition regulations. The acquisition was completed without significant legal hurdles, reflecting its alignment with both companies’ strategic objectives.